Literature DB >> 2426196

Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi.

R A Wrightsman, W Leon, J E Manning.   

Abstract

Monoclonal antibodies reactive with the surface antigens of the Peru strain of Trypanosoma cruzi were analyzed by Western blots and immunofluorescence assays to determine their reactivity with three life cycle stages and five strain isolates of T. cruzi. One monoclonal antibody, 7.6, recognized a 68-kilodalton (kDa) polypeptide in Western blots of Peru strain trypomastigotes, epimastigotes, and amastigotes. A 68-kDa polypeptide was also detected by monoclonal antibody 7.6 in trypomastigotes of the CL and Y strains and in the clonal isolates Esmeraldo clone 3 and Silvio X10 clone 1. Positive immunofluorescence results were obtained for all life cycle stages of the five strains that were reacted with monoclonal antibody 7.6, thus indicating that the antigen recognized by monoclonal antibody 7.6 is universally present in all T. cruzi strains tested. In contrast, monoclonal antibody 4.2 reacted with a polypeptide doublet of 90 and 105 kDa in Western blots of Peru strain trypomastigotes, but it did not detect these antigens in epimastigotes or amastigotes. The same polypeptide doublet of 90 and 105 kDa was also detected in Western blots of Y strain trypomastigotes; however, no bands were detected in blots of strain CL or isolate Silvio X10 clone 1 trypomastigotes. In blots of Esmeraldo clone 3 trypomastigotes, a single band of 130 kDa was detected by monoclonal antibody 4.2. In immunofluorescence assays of monoclonal antibody 4.2, positive reactions were obtained only with trypomastigotes of Peru, Y, and Esmeraldo clone 3 strains. Thus, monoclonal antibody 4.2 recognizes a trypomastigote-specific antigen which is not universally present on all strains of T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426196      PMCID: PMC260863          DOI: 10.1128/iai.53.2.235-239.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Zymodeme and species specificities of monoclonal antibodies raised against Trypanosoma cruzi.

Authors:  J E Flint; M Schechter; M D Chapman; M A Miles
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

2.  Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.

Authors:  C L Jaffe; E Bennett; G Grimaldi; D McMahon-Pratt
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

3.  Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions.

Authors:  C K Grant; B J Ernisse; O Jarrett; F R Jones
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  Trypanosoma cruzi: biological characterization of 19 clones derived from two chronic chagasic patients. I. Growth kinetics in liquid medium.

Authors:  J C Engel; J A Dvorak; E L Segura; M S Crane
Journal:  J Protozool       Date:  1982-11

5.  Purification and regulatory properties of the NADP-linked malic enzyme for Crithidia fasciculata.

Authors:  E Orellano; J J Cazzulo
Journal:  Mol Biochem Parasitol       Date:  1981-05       Impact factor: 1.759

6.  Monoclonal antibodies to stages of Trypanosoma cruzi: characterization and use for antigen detection.

Authors:  F G Araujo; S D Sharma; V Tsai; P Cox; J S Remington
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source.

Authors:  M Postan; J A Dvorak; J P McDaniel
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

8.  A Mr 90 000 surface polypeptide of Trypanosoma cruzi as a candidate for a Chagas' disease diagnostic antigen.

Authors:  E A Dragon; V M Brothers; R A Wrightsman; J Manning
Journal:  Mol Biochem Parasitol       Date:  1985-09       Impact factor: 1.759

9.  Type-common and type-specific monoclonal antibody to herpes simplex virus type 1.

Authors:  L Pereira; T Klassen; J R Baringer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Surface antigens of stocks and clones of Trypanosoma cruzi isolated from humans.

Authors:  B Zingales; G Abuin; A J Romanha; E Chiari; W Colli
Journal:  Acta Trop       Date:  1984-03       Impact factor: 3.112

View more
  5 in total

1.  The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases.

Authors:  S Kahn; T G Colbert; J C Wallace; N A Hoagland; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi.

Authors:  Jenny L Hardison; Ruth A Wrightsman; Philip M Carpenter; Thomas E Lane; Jerry E Manning
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Serodiagnosis of Chagas' disease using monoclonal antibody against Trypanosoma cruzi-specific Mr 25,000 antigen.

Authors:  H Tachibana; K Nagakura; Y Kaneda
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

4.  The 85-kd surface antigen gene of Trypanosoma cruzi is telomeric and a member of a multigene family.

Authors:  D S Peterson; D L Fouts; J E Manning
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

5.  The major 85-kD surface antigen of the mammalian form of Trypanosoma cruzi is encoded by a large heterogeneous family of simultaneously expressed genes.

Authors:  S Kahn; W C Van Voorhis; H Eisen
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.